Free tool
FAERS Monitor: Tudorza Pressair
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 202450 or its brand name (Tudorza Pressair, Aclidinium Bromide). Reports on generic versions are filed under their own applications.
Reports
6,392
Serious
3,559
56% of reports
Hospitalization
1,901
Death reported
290
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea1,875
- device malfunction1,282
- drug dose omission1,017
- asthma819
- chronic obstructive pulmonary disease784
- intentional product misuse741
- off label use720
- pneumonia718
- wheezing666
- cough658
- product quality issue592
- device issue475
- obstructive airways disorder450
- drug ineffective413
- malaise392
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 12 |
| 2013 | 221 |
| 2014 | 339 |
| 2015 | 631 |
| 2016 | 862 |
| 2017 | 912 |
| 2018 | 875 |
| 2019 | 472 |
| 2020 | 385 |
| 2021 | 421 |
| 2022 | 402 |
| 2023 | 329 |
| 2024 | 262 |
| 2025 | 175 |
| 2026 | 81 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,767 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| obstructive airways disorderSignal | 450 | 138.7 | 126.6 | 58,938 |
| device malfunctionSignal | 1,282 | 61.1 | 58.2 | 74,629 |
| chronic obstructive pulmonary diseaseSignal | 784 | 50.2 | 47.0 | 37,264 |
| wheezingSignal | 666 | 37.4 | 34.8 | 23,335 |
| intentional product misuseSignal | 741 | 28.1 | 26.2 | 19,241 |
| asthmaSignal | 819 | 24.0 | 22.5 | 18,006 |
| drug dose omissionSignal | 1,017 | 20.4 | 19.2 | 18,738 |
| device issueSignal | 475 | 17.5 | 16.1 | 7,373 |
| product quality issueSignal | 592 | 14.4 | 13.3 | 7,385 |
| dyspnoeaSignal | 1,875 | 10.9 | 10.5 | 17,319 |
| coughSignal | 658 | 7.7 | 7.2 | 3,896 |
| pneumoniaSignal | 718 | 7.3 | 6.8 | 3,958 |
| malaiseSignal | 392 | 2.9 | 2.7 | 511 |
| off label useSignal | 720 | 2.7 | 2.5 | 806 |
| drug ineffective | 413 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.